Anglo American Valuation
Is ANGL-EQO undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ANGL-EQO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ANGL-EQO (BWP469.11) is trading above our estimate of fair value (BWP359.18)
Significantly Below Fair Value: ANGL-EQO is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ANGL-EQO?
Other financial metrics that can be useful for relative valuation.
What is ANGL-EQO's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$38.80b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.9x |
Enterprise Value/EBITDA | 6.1x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does ANGL-EQO's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 4.3x | ||
GMEXICO B Grupo México. de | 2.9x | 4.5% | Mex$853.7b |
1211 Saudi Arabian Mining Company (Ma'aden) | 6.2x | 7.8% | ر.س178.7b |
500188 Hindustan Zinc | 7.2x | 8.3% | ₹2.1t |
3993 CMOC Group | 0.8x | 3.9% | HK$199.0b |
ANGL-EQO Anglo American | 1.3x | 2.2% | P29.7b |
Price-To-Sales vs Peers: ANGL-EQO is good value based on its Price-To-Sales Ratio (1.3x) compared to the peer average (4.3x).
Price to Earnings Ratio vs Industry
How does ANGL-EQO's PE Ratio compare vs other companies in the African Metals and Mining Industry?
Price-To-Sales vs Industry: ANGL-EQO is good value based on its Price-To-Sales Ratio (1.3x) compared to the African Metals and Mining industry average (1.3x).
Price to Sales Ratio vs Fair Ratio
What is ANGL-EQO's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 1.3x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate ANGL-EQO's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | P469.11 | P431.84 -7.9% | 11.3% | P515.50 | P352.02 | n/a | 17 |
Oct ’25 | P469.11 | P427.56 -8.9% | 11.0% | P508.75 | P347.41 | n/a | 17 |
Sep ’25 | P469.11 | P438.89 -6.4% | 11.5% | P529.22 | P358.31 | n/a | 17 |
Aug ’25 | P469.11 | P452.89 -3.5% | 10.5% | P539.25 | P365.25 | n/a | 17 |
Jul ’25 | P469.11 | P458.08 -2.4% | 11.3% | P535.94 | P345.96 | n/a | 18 |
Jun ’25 | P469.11 | P468.79 -0.07% | 12.2% | P557.74 | P352.22 | n/a | 17 |
May ’25 | P462.00 | P420.45 -9.0% | 18.1% | P532.97 | P272.47 | n/a | 14 |
Apr ’25 | P392.00 | P376.90 -3.9% | 14.3% | P468.12 | P277.12 | n/a | 19 |
Mar ’25 | P392.00 | P378.74 -3.4% | 14.1% | P470.70 | P278.93 | n/a | 19 |
Feb ’25 | P392.00 | P394.74 +0.7% | 17.2% | P578.43 | P276.63 | n/a | 19 |
Jan ’25 | P392.00 | P395.18 +0.8% | 18.8% | P571.44 | P252.96 | n/a | 18 |
Dec ’24 | P392.00 | P447.97 +14.3% | 11.0% | P574.53 | P375.10 | n/a | 18 |
Nov ’24 | P392.00 | P448.46 +14.4% | 12.1% | P581.60 | P344.40 | n/a | 18 |
Oct ’24 | P392.00 | P462.66 +18.0% | 12.9% | P601.31 | P376.59 | P469.11 | 18 |
Sep ’24 | P392.00 | P458.33 +16.9% | 12.1% | P588.33 | P373.11 | P469.11 | 19 |
Aug ’24 | P392.00 | P452.98 +15.6% | 12.2% | P573.62 | P363.78 | P469.11 | 19 |
Jul ’24 | P218.00 | P494.56 +126.9% | 13.7% | P587.53 | P381.92 | P469.11 | 19 |
Jun ’24 | P218.00 | P543.36 +149.2% | 16.1% | P735.75 | P385.19 | P469.11 | 20 |
May ’24 | P218.00 | P523.74 +140.2% | 16.4% | P704.65 | P367.19 | P462.00 | 19 |
Apr ’24 | P218.00 | P516.17 +136.8% | 17.4% | P681.14 | P363.48 | P392.00 | 19 |
Mar ’24 | P218.00 | P539.30 +147.4% | 16.2% | P685.66 | P410.21 | P392.00 | 20 |
Feb ’24 | P218.00 | P536.91 +146.3% | 16.3% | P680.37 | P397.56 | P392.00 | 20 |
Jan ’24 | P218.00 | P514.91 +136.2% | 14.6% | P641.08 | P397.56 | P392.00 | 21 |
Dec ’23 | P218.00 | P514.09 +135.8% | 14.7% | P641.08 | P358.23 | P392.00 | 21 |
Nov ’23 | P218.00 | P521.06 +139.0% | 15.3% | P668.58 | P373.59 | P392.00 | 21 |
Oct ’23 | P218.00 | P530.85 +143.5% | 14.0% | P697.18 | P415.37 | P392.00 | 22 |
Analyst Forecast: Target price is less than 20% higher than the current share price.